Uplaksh Kumar

Dr. Kumar is a Venture Partner at Foresite Capital, and brings extensive experience in cancer diagnostics and operations, having formerly worked as the SVP of Strategic Operations and Scale at GRAIL, where he launched Galleri®, the first of its kind early detection blood test. Prior to his role at GRAIL, Uplaksh was the first head of operations at Verily, and has held various leadership positions at Life Technologies, BD, LONZA, and Qiagen. Throughout his career, Dr. Kumar has been instrumental in driving growth and innovation in the companies he has worked with. Uplaksh holds a B.S. in Pharmaceutical Sciences from the University of Mumbai, a Ph.D. in Pharmaceutical Sciences from the University of Maryland, and an MBA from the Wharton School at the University of Pennsylvania.